Nidanilimab (Anti-IL-1RAP / IL-1R3)
Product Specifications
CAS Number
2171061-85-9
Synonyms
CAN04
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) . MW :143.56 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401003-500 1x 500 µL
Mucin 5AC (MUC5AC) (58M1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680709-100 1x 100 µL
Human Kappa Light Chain (KLC709), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681469-500 1x 500 µL
MCM7 (Proliferation Marker) (MCM7/1469), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details